In this nonrandomized study of previously untreated patients with multiple myeloma, the addition of interferon in a dose of 3 mu/m2/day to dexamethasone achieved results similar to those with dexamethasone alone.
David S. Siegel, Paul G. Richardson, Meletios A Dimopoulos, Philippe Moreau, C Mitsiades, D. Weber, Jennifer Houp, Christine K. Gause, Scott Vuocolo, Joe Eid, Thorsten Graef, Kenneth C. Anderson
Discussion(0)
No comments yet. Be the first to comment.